Regulation of β-amyloid level in the brain of rats with cerebrovascular hypoperfusion

Neurobiology of Aging

Volumn 33, Issue 4, 2012, Pages 826.e31-826.e42

  Liu, Hong ^a   Xing, Anfeng ^a   Wang, Xiaojuan ^a   Liu, Guozhen ^a   Li, Liang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid clearance; Amyloid protein; Cerebrovascular hypoperfusion; Spatial memory

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA AMYLOID RECEPTOR PROTEIN; BETA SECRETASE; BRAIN PROTEIN; GAMMA SECRETASE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SPATIAL MEMORY; WESTERN BLOTTING;

EID: 84856956385     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.05.027     Document Type: Article

References (51)

1. Altieri M., Di Piero V., Pasquini M., Gasparini M., Vanacore N., Vicenzini E., Lenzi G.L. Delayed poststroke dementia: a 4-year follow-up study. Neurology 2004, 62:2193-2197.
2. Bell R.D., Deane R., Chow N., Long X., Sagare A., Singh I., Streb J.W., Guo H., Rubio A., Van Nostrand W., Miano J.M., Zlokovic B.V. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat. Cell Biol 2009, 11:143-153.
3. Bell R.D., Sagare A.P., Friedman A.E., Bedi G.S., Holtzman D.M., Deane R., Zlokovic B.V. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab 2007, 27:909-918.
4. Bell R.D., Zlokovic B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009, 118:103-113.
5. Borroni B., Grassi M., Agosti C., Costanzi C., Archetti S., Franzoni S., Caltagirone C., Di Luca M., Caimi L., Padovani A. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol. Aging 2006, 27:1595-1603.
6. Cada A., De la Torre J.C., Gonzalez-Lima F. Chronic cerebrovascular ischemia in aged rats: effects on brain metabolic capacity and behavior. Neurobiol. Aging 2000, 21:225-233.
7. Cai Z., Yan Y., Sun S., Zhang J., Huang L., Yan L., Li J. Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease. Neurochem. Resources 2009, 34:1226-1235.
8. Chen M., Inestrosa N.C., Ross G.S., Fernandez H.L. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem. Biophys. Res. Commun 1995, 213:96-103.
9. de la Torre J.C., Pappas B.A., Prevot V., Emmerling M.R., Mantione K., Fortin T., Watson M.D., Stefano G.B. Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats. Neurol. Res 2003, 25:635-641.
10. de la Torre J.C., Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Rev 2000, 34:119-136.
11. Deane R., Bell R.D., Sagare A., Zlokovic B.V. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2009, 8:16-30.
12. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat. Med 2003, 9:907-913.
13. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., Xu F., Parisi M., LaRue B., Hu H.W., Spijkers P., Guo H., Song X., Lenting P.J., Van Nostrand W.E., Zlokovic B. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 2004, 43:333-344.
14. Deane R., Wu Z., Zlokovic B.V. RAGE (yin) versus LRP (yang) balance regulates Alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 2004, 35:2628-2631.
15. Deane R., Zlokovic B.V. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res 2007, 4:191-197.
16. Donahue J.E., Flaherty S.L., Johanson C.E., Duncan J.A., Silverberg G.D., Miller M.C., Tavares R., Yang W., Wu Q., Sabo E., Hovanesian V., Stopa E.G. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 2006, 112:405-415.
17. Fisk L., Nalivaeva N.N., Boyle J.P., Peers C.S., Turner A.J. Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem. Res 2007, 32:1741-1748.
18. Graff-Radford N.R., Crook J.E., Lucas J., Boeve B.F., Knopman D.S., Ivnik R.J., Smith G.E., Younkin L.H., Petersen R.C., Younkin S.G. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch. Neurol 2007, 64:354-362.
19. Hansson O., Zetterberg H., Vanmechelen E., Vanderstichele H., Andreasson U., Londos E., Wallin A., Minthon L., Blennow K. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol. Aging 2010, 31:357-367.
20. Hardy J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem 2009, 110:1129-1134.
21. Hellström-Lindahl E., Ravid R., Nordberg A. Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiol. Aging 2008, 29:210-221.
22. Jeynes B., Provias J. Evidence for altered LRP/RAGE expression in Alzheimer lesion pathogenesis. Curr. Alzheimer Res 2008, 5:432-437.
23. Lahiri D.K., Maloney B., Basha M.R., Ge Y.W., Zawia N.H. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARN" model (Latent Early-Life Associated Regulation) may explain the triggering of AD. Curr. Alzheimer Res 2007, 4:219-228.
24. LaRue B., Hogg E., Sagare A., Jovanovic S., Maness L., Maurer C., Deane R., Zlokovic B.V. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice. J. Neurosci. Meth 2004, 138:233-242.
25. Lee P.H., Bang O.Y., Hwang E.M., Lee J.S., Joo U.S., Mook-Jung I., Huh K. Circulating beta amyloid protein is elevated in patients with acute ischemic stroke. J. Neural. Transm 2005, 112:1371-1379.
26. Madani R., Poirier R., Wolfer D.P., Welzl H., Groscurth P., Lipp H.P., Lu B., El Mouedden M., Mercken M., Nitsch R.M., Mohajeri M.H. Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo. J. Neurosci. Res 2006, 84:1871-1878.
27. Martins I.J., Hone E., Foster J.K., Sünram-Lea S.I., Gnjec A., Fuller S.J., Nolan D., Gandy S.E., Martins R.N. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors forAlzheimer's disease and cardiovascular disease. Mol. Psychiatry 2006, 11:721-736.
28. Ni J., Ohta H., Matsumoto K., Watanabe H. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res 1994, 653:231-236.
29. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1997, Academic Press, London.
30. Praticò D. Alzheimer's disease and oxygen radicals: new insights. Biochem. Pharmacol 2002, 63:563-567.
31. Saido T.C. Overview Aβ metabolism: from Alzheimer research to brain aging control. Aβ Metabolism and Alzheimer's Disease 2003, 1-16. Texas' Landes Bioscience, TX,USA. T.C. Saido (Ed.).
32. Sasaki N., Toki S., Chowei H., Saito T., Nakano N., Hayashi Y., Takeuchi M., Makita Z. Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res 2001, 888:256-262.
33. Schneider J.A., Wilson R.S., Cochran E.J., Bienias J.L., Arnold S.E., Evans D.A., Bennett D.A. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 2003, 60:1082-1088.
34. Schupf N., Tang M.X., Fukuyama H., Manly J., Andrews H., Mehta P., Ravetch J., Mayeux R. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A 2008, 105:14052-14057.
35. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron 2001, 32:177-180.
36. Seubert P., Oltersdorf T., Lee M.G., Barbour R., Blomquist C., Davis D.L., Bryant K., Fritz L.C., Galasko D., Thal L.J., Lieberburg I., Schenk D.B. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 1993, 361:260-263.
37. Shibata M., Ohtani R., Ihara M., Tomimoto H. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke 2004, 35:2598-2603.
38. Shibata M., Yamada S., Kumar S.R., Calero M., Bading J., Frangione B., Holtzman D.M., Miller C.A., Strickland D.K., Ghiso J., Zlokovic B.V. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest 2000, 106:1489-1499.
39. Stewart P.A., Hayakawa K., Akers M.A., Vinters H.V. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab. Invest 1992, 67:734-742.
40. Sun M.K., Xu H., Alkon D.L. Pharmacological protection of synaptic function, spatial learning, and memory from transient hypoxia in rats. J. Pharmacol. Exp. Ther 2002, 300:408-416.
41. Tanzi R.E., Moir R.D., Wagner S.L. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 2004, 43:605-608.
42. Tomimoto H., Ihara M., Wakita H., Ohtani R., Lin J.X., Akiguchi I., Kinoshita M., Shibasaki H. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol 2003, 106:527-534.
43. Vermeer S.E., Prins N.D., den Heijer T., Hofman A., Koudstaal P.J., Breteler M.M. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J. Med 2003, 348:1215-1222.
44. Wang R., Zhang Y.W., Zhang X., Liu R., Zhang X., Hong S., Xia K., Xia J., Zhang Z., Xu H. Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J 2006, 20:1275-1277.
45. Wang X., Xing A., Xu C., Cai Q., Liu H., Li L. Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats. J. Alzheimers Dis 2010, 21:813-822.
46. Weller R.O., Boche D., Nicoll J.A. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol 2009, 118:87-102.
47. Wu Z., Guo H., Chow N., Sallstrom J., Bell R.D., Deane R., Brooks A.I., Kanagala S., Rubio A., Sagare A., Liu D., Li F., Armstrong D., Gasiewicz T., Zidovetzki R., Song X., Hofman F., Zlokovic B.V. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat. Med 2005, 11:959-965.
48. Yan F.L., Zheng Y., Zhao F.D. Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Acta Neuropathol 2008, 116:529-535.
49. Zhang X., Zhou K., Wang R., Cui J., Lipton S.A., Liao F.F., Xu H., Zhang Y.W. Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem 2007, 282:10873-10880.
50. Zheng H., Xu H., Uljon S.N., Gross R., Hardy K., Gaynor J., Lafrancois J., Simpkins J., Refolo L.M., Petanceska S., Wang R., Duff K. Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem 2002, 80:191-196.
51. Zlokovic B.V. Clearing amyloid through the blood-brain barrier. J. Neurochem 2004, 89:807-811.